help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blyth, D. I.
Right arrow Articles by Sanjar, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blyth, D. I.
Right arrow Articles by Sanjar, S.

Am. J. Respir. Cell Mol. Biol., Volume 23, Number 2, August, 2000 241-246

Airway Subepithelial Fibrosis in a Murine Model of Atopic Asthma
Suppression by Dexamethasone or Anti-Interleukin-5 Antibody

David I. Blyth, Tsumi F. Wharton, Michael S. Pedrick, Tony J. Savage, and Shahin Sanjar

Respiratory Diseases and Molecular Pathology Units, Glaxo Wellcome Research and Development, Stevenage, Hertfordshire, United Kingdom

Fibrosis in the reticular layer beneath the epithelial basement membrane is a feature of airway remodeling in human asthma. We previously reported the presence of subepithelial fibrosis (SEF) in a disease model of atopic asthma in which mice were sensitized and intratracheally challenged with ovalbumin (OVA) (Blyth and colleagues, Am. J. Respir. Cell Mol. Biol. 1996;14:425-438). Here, we describe further studies to quantify the degree of SEF after its induction by repeated exposure of the airways to allergen. The amount of subepithelial reticulin in the airways of animals challenged three times with 80 µg OVA was typically increased 1.4-fold. The increased amount of reticulin showed no reduction after a 50-d period after the third allergen challenge. A reduction in SEF was achieved by daily treatment with dexamethasone (DEX) for 8 d during the allergen challenge period, or by treatment with anti-interleukin-5 antibody (TRFK5) at the time of allergen challenge. Postchallenge treatment with DEX for 15 d resulted in significant resolution of previously established SEF. Severe nonallergic inflammation during repeated exposure of airways to lipopolysaccharide did not induce SEF. The results indicate that development of SEF is associated with eosinophil infiltration into airways, and may occur only when the inflammatory stimulus is allergic in nature.




This article has been cited by other articles:


Home page
Eur Respir JHome page
E. H. Walters, D. W. Reid, D. P. Johns, and C. Ward
Nonpharmacological and pharmacological interventions to prevent or reduce airway remodelling
Eur. Respir. J., September 1, 2007; 30(3): 574 - 588.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
E. D. Fixman, A. Stewart, and J. G. Martin
Basic mechanisms of development of airway structural changes in asthma
Eur. Respir. J., February 1, 2007; 29(2): 379 - 389.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Wenzel and S. T. Holgate
The Mouse Trap: It Still Yields Few Answers in Asthma
Am. J. Respir. Crit. Care Med., December 1, 2006; 174(11): 1173 - 1176.
[Full Text] [PDF]


Home page
Eur Respir JHome page
S. Saglani, C. Molyneux, H. Gong, A. Rogers, K. Malmstrom, A. Pelkonen, M. Makela, E. Adelroth, A. Bush, D. N. R. Payne, et al.
Ultrastructure of the reticular basement membrane in asthmatic adults, children and infants
Eur. Respir. J., September 1, 2006; 28(3): 505 - 512.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. Bergeron and L.-P. Boulet
Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation.
Chest, April 1, 2006; 129(4): 1068 - 1087.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
W. R. Henderson Jr., G. K. S. Chiang, Y.-t. Tien, and E. Y. Chi
Reversal of Allergen-induced Airway Remodeling by CysLT1 Receptor Blockade
Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 718 - 728.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Lopez, V. del Pozo, T. Miguel, B. Sastre, C. Seoane, E. Civantos, E. Llanes, M. L. Baeza, P. Palomino, B. Cardaba, et al.
Inhibition of Chronic Airway Inflammation and Remodeling by Galectin-3 Gene Therapy in a Murine Model
J. Immunol., February 1, 2006; 176(3): 1943 - 1950.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Miller, J. Y. Cho, K. McElwain, S. McElwain, J. Y. Shim, M. Manni, J. S. Baek, and D. H. Broide
Corticosteroids prevent myofibroblast accumulation and airway remodeling in mice
Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L162 - L169.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. Tomic, C. C. Lassiter, J. D. Ritzenthaler, H. N. Rivera, and J. Roman
Anti-Tissue Remodeling Effects of Corticosteroids: Fluticasone Propionate Inhibits Fibronectin Expression in Fibroblasts
Chest, January 1, 2005; 127(1): 257 - 265.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. K. Kumar, C. Herbert, D. C. Webb, L. Li, and P. S. Foster
Effects of Anticytokine Therapy in a Mouse Model of Chronic Asthma
Am. J. Respir. Crit. Care Med., November 15, 2004; 170(10): 1043 - 1048.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
A. A. Humbles, C. M. Lloyd, S. J. McMillan, D. S. Friend, G. Xanthou, Erin. E. McKenna, S. Ghiran, N. P. Gerard, C. Yu, S. H. Orkin, et al.
A Critical Role for Eosinophils in Allergic Airways Remodeling
Science, September 17, 2004; 305(5691): 1776 - 1779.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P.E. Christie, M. Jonas, C-H. Tsai, E.Y. Chi, and W.R. Henderson Jr
Increase in laminin expression in allergic airway remodelling and decrease by dexamethasone
Eur. Respir. J., July 1, 2004; 24(1): 107 - 115.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
H. Tanaka, M. Komai, K. Nagao, M. Ishizaki, D. Kajiwara, K. Takatsu, G. Delespesse, and H. Nagai
Role of Interleukin-5 and Eosinophils in Allergen-Induced Airway Remodeling in Mice
Am. J. Respir. Cell Mol. Biol., July 1, 2004; 31(1): 62 - 68.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. K. Kumar, C. Herbert, P. S. Thomas, L. Wollin, R. Beume, M. Yang, D. C. Webb, and P. S. Foster
Inhibition of Inflammation and Remodeling by Roflumilast and Dexamethasone in Murine Chronic Asthma
J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 349 - 355.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J.C. Kips, G.P. Anderson, J.J. Fredberg, U. Herz, M.D. Inman, M. Jordana, D.M. Kemeny, J. Lotvall, R.A. Pauwels, C.G. Plopper, et al.
Murine models of asthma
Eur. Respir. J., August 1, 2003; 22(2): 374 - 382.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
P A Beckett and P H Howarth
Pharmacotherapy and airway remodelling in asthma?
Thorax, February 1, 2003; 58(2): 163 - 174.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
N.J. Vanacker, E. Palmans, R.A. Pauwels, and J.C. Kips
Dose-related effect of inhaled fluticasone on allergen-induced airway changes in rats
Eur. Respir. J., October 1, 2002; 20(4): 873 - 879.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P.J. Barnes
Cytokine modulators as novel therapies for airway disease
Eur. Respir. J., July 2, 2001; 18(34_suppl): 67S - 77s.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2000 American Thoracic Society.